Published in J Heart Lung Transplant on March 21, 2011
Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients. PLoS One (2012) 1.40
Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation. Semin Respir Crit Care Med (2013) 0.98
Immunosuppression in lung transplantation. J Thorac Dis (2014) 0.92
Psychiatric Predictors of Long-term Transplant-Related Outcomes in Lung Transplant Recipients. Transplantation (2016) 0.77
Elevated CXCL10 (IP-10) in bronchoalveolar lavage fluid is associated with acute cellular rejection after human lung transplantation. Transplantation (2014) 0.77
Mathematical Modeling of Early Cellular Innate and Adaptive Immune Responses to Ischemia/Reperfusion Injury and Solid Organ Allotransplantation. Front Immunol (2015) 0.76
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant (2002) 5.49
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant (2007) 3.90
Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant (1996) 3.51
Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant (2003) 2.83
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation (2003) 2.48
The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010. J Heart Lung Transplant (2010) 2.43
Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med (2004) 1.85
Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. Am J Transplant (2008) 1.67
Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med (1999) 1.44
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43
Alemtuzumab induction prior to cardiac transplantation with lower intensity maintenance immunosuppression: one-year outcomes. Am J Transplant (2009) 1.41
Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant (2005) 1.31
Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Am J Respir Crit Care Med (2008) 1.30
Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation (2003) 1.28
Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis (2006) 1.23
Lung transplantation in the United States, 1999-2008. Am J Transplant (2010) 1.21
Invasive aspergillosis in solid organ transplant recipients. Am J Transplant (2009) 1.18
Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg (2005) 1.10
The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int (2006) 1.08
Immunobiology of chronic lung allograft dysfunction: new insights from the bench and beyond. Am J Transplant (2009) 1.07
Alemtuzumab (Campath-1H): a systematic review in organ transplantation. Transplantation (2006) 1.04
Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab. Am J Transplant (2007) 1.04
Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. Transplantation (2004) 0.99
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. Am J Transplant (2008) 0.98
Lung transplantation in the United States, 1998-2007. Am J Transplant (2009) 0.97
Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transpl Int (2008) 0.96
Lung allograft rejection: diagnosis and management. Curr Opin Organ Transplant (2009) 0.95
Immunosuppression for lung transplantation. Proc Am Thorac Soc (2009) 0.94
Alemtuzumab (Campath-1H) induction in a pediatric heart transplant: successful outcome and rationale for its use. J Heart Lung Transplant (2008) 0.91
Current trends in immunosuppression for lung transplantation. Semin Respir Crit Care Med (2010) 0.91
Evidence for immunosuppression in lung transplantation. Curr Opin Organ Transplant (2008) 0.88
Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis. J Heart Lung Transplant (2010) 0.86
Campath induction for kidney transplantation: report of 297 cases. Transplantation (2008) 0.81
Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion. J Infect (2006) 0.78
Early outcomes using alemtuzumab induction in lung transplantation. Interact Cardiovasc Thorac Surg (2009) 0.77
clinical research, innovative practice and IRB review: identifying and respecting boundaries. Am J Transplant (2007) 0.77
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med (2008) 9.05
Maintenance treatment of major depression in old age. N Engl J Med (2006) 7.61
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med (2010) 6.23
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant (2007) 3.90
The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor. Transplantation (2006) 3.24
The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry (2004) 3.17
A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med (2006) 3.16
Epithelial Na+ channels are fully activated by furin- and prostasin-dependent release of an inhibitory peptide from the gamma-subunit. J Biol Chem (2007) 3.09
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax (2011) 2.84
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol (2009) 2.70
Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One (2008) 2.67
Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial. JAMA (2009) 2.60
Procuring organ donors as a health investment: how much should we be willing to spend? Transplantation (2004) 2.47
Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A (2004) 2.42
Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int (2009) 2.35
Initial experience with single cannulation for venovenous extracorporeal oxygenation in adults. Ann Thorac Surg (2010) 2.35
Prevalence of behavioral symptoms: comparison of the minimum data set assessments with research instruments. J Am Med Dir Assoc (2008) 2.25
Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry (2013) 2.23
Palliative care referrals after lung transplantation in major transplant centers in the United States. Crit Care Med (2009) 2.13
Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling. Am J Transplant (2004) 2.09
Muscle mass predicts outcomes following liver transplantation. Liver Transpl (2013) 2.04
Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl (2006) 2.02
Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry. Ann Thorac Surg (2012) 1.99
Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.94
User-centered design and interactive health technologies for patients. Comput Inform Nurs (2009) 1.93
Onset of depression in elderly persons after hip fracture: implications for prevention and early intervention of late-life depression. J Am Geriatr Soc (2007) 1.85
Palliative care and location of death in decedents with idiopathic pulmonary fibrosis. Chest (2015) 1.85
Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS (2004) 1.84
The epithelial Na+ channel is inhibited by a peptide derived from proteolytic processing of its alpha subunit. J Biol Chem (2006) 1.80
Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both. J Heart Lung Transplant (2009) 1.78
Patient suffering and caregiver compassion: new opportunities for research, practice, and policy. Gerontologist (2007) 1.77
Airway surface liquid volume regulates ENaC by altering the serine protease-protease inhibitor balance: a mechanism for sodium hyperabsorption in cystic fibrosis. J Biol Chem (2006) 1.77
Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses. Am J Respir Crit Care Med (2013) 1.77
Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. Am J Psychiatry (2005) 1.76
The relationship between pain and mental flexibility in older adult pain clinic patients. Pain Med (2006) 1.75
Race and ethnicity in decisions about unrelated hematopoietic stem cell donation. Blood (2012) 1.73
A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol (2011) 1.71
Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study. J Clin Biochem Nutr (2010) 1.70
Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1. Cardiovasc Res (2012) 1.69
Effect of rehabilitation site on functional recovery after hip fracture. Arch Phys Med Rehabil (2005) 1.69
Cognitive impairment in late-life generalized anxiety disorder. Am J Geriatr Psychiatry (2007) 1.67
Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res (2010) 1.65
Can performance on daily activities discriminate between older adults with normal cognitive function and those with mild cognitive impairment? J Am Geriatr Soc (2014) 1.65
Age-specific complications among lung transplant recipients 60 years and older. J Heart Lung Transplant (2010) 1.61
Occurrence and course of suicidality during short-term treatment of late-life depression. Arch Gen Psychiatry (2003) 1.60
Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry (2007) 1.60
Striving for normalcy: symptoms and the threat of rejection after lung transplantation. Soc Sci Med (2004) 1.56
Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl (2005) 1.55
Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry (2009) 1.54
Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant (2011) 1.51
Adverse effects of depression and cognitive impairment on rehabilitation participation and recovery from hip fracture. Int J Geriatr Psychiatry (2004) 1.51
Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant (2010) 1.51
Hydrogen preconditioning during ex vivo lung perfusion improves the quality of lung grafts in rats. Transplantation (2014) 1.51
Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. J Am Geriatr Soc (2007) 1.50
Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry (2011) 1.48
Accidental insertion of a percutaneous venovenous cannula into the persistent left superior vena cava of a patient undergoing liver transplantation. Can J Anaesth (2011) 1.46
Single-lung transplantation can be performed with acceptable outcomes using selected donors with heavy smoking history. J Heart Lung Transplant (2013) 1.46
HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant (2005) 1.46
Monitoring alcohol use on the liver transplant wait list: therapeutic and practical issues. Liver Transpl (2012) 1.45
Hydrogen-supplemented drinking water protects cardiac allografts from inflammation-associated deterioration. Transpl Int (2012) 1.44
The Pittsburgh Rehabilitation Participation Scale: reliability and validity of a clinician-rated measure of participation in acute rehabilitation. Arch Phys Med Rehabil (2004) 1.44
Impact of renal function before mechanical circulatory support on posttransplant renal outcomes. Ann Thorac Surg (2011) 1.44
SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia. J Gen Physiol (2009) 1.44
Growing experience with extracorporeal membrane oxygenation as a bridge to lung transplantation. ASAIO J (2012) 1.43
Shock-related anxiety and sexual function in adults with congenital heart disease and implantable cardioverter-defibrillators. Heart Rhythm (2013) 1.43
Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol (2003) 1.43
Adenosine injection prior to cardioplegia enhances preservation of senescent hearts in rat heterotopic heart transplantation. Eur J Cardiothorac Surg (2012) 1.42
Profiling molecular changes induced by hydrogen treatment of lung allografts prior to procurement. Biochem Biophys Res Commun (2012) 1.42
The burden of late-life generalized anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization. Am J Geriatr Psychiatry (2009) 1.41
Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis. J Immunol (2007) 1.39
Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes. Ann Thorac Surg (2011) 1.39
Somatic symptoms of depression in elderly patients with medical comorbidities. Int J Geriatr Psychiatry (2005) 1.39
High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Diagn Microbiol Infect Dis (2011) 1.38
Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis (2009) 1.34
Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum (2011) 1.33
Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg (2009) 1.30
Therapeutic antioxidant medical gas. J Clin Biochem Nutr (2008) 1.29
Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med (2003) 1.28
HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant (2004) 1.27
Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5. J Biol Chem (2002) 1.27
AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol (2009) 1.27
Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest (2010) 1.27
Intelligent assistive technology applications to dementia care: current capabilities, limitations, and future challenges. Am J Geriatr Psychiatry (2009) 1.26
Adherence to the medical regimen during the first two years after lung transplantation. Transplantation (2008) 1.26
Social inequalities in response to antidepressant treatment in older adults. Arch Gen Psychiatry (2006) 1.25
Evaluation of a hand-held, computer-based intervention to promote early self-care behaviors after lung transplant. Clin Transplant (2009) 1.24
Caregiving burden and psychiatric morbidity in spouses of persons with mild cognitive impairment. Int J Geriatr Psychiatry (2005) 1.24
Sleep quality and its correlates in the first year of dialysis. Clin J Am Soc Nephrol (2006) 1.23
Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis (2006) 1.23
Building PROMIS item banks: librarians as co-investigators. Qual Life Res (2009) 1.22
Prostasin expression is regulated by airway surface liquid volume and is increased in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol (2008) 1.21